Sign In
Buy VERU
$2.25
-0.100 (-4.26%)
At Close: Jun 03, 2026
Veru Enrolls First Patient in Phase 3 Clinical Trial of Sabizabulin (VERU-111) in High Risk Hospitalized COVID-19 Patients
08:30am, Wednesday, 19'th May 2021
—Sabizabulin is a novel oral agent with both anti-viral and anti-inflammatory activities—
Veru, Inc. (VERU) CEO Mitchell Steiner on Q2 2021 Results - Earnings Call Transcript
03:17pm, Wednesday, 12'th May 2021
Veru, Inc. (VERU) CEO Mitchell Steiner on Q2 2021 Results - Earnings Call Transcript
Veru: Q2 Earnings Insights
07:08am, Wednesday, 12'th May 2021
Shares of Veru (NASDAQ:VERU) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share fell 300.00% over the past year to ($0.04), which were in line with the est
Veru Reports Strong Second-Quarter Financial Results Based on Record High FC2 Prescription Revenues
06:30am, Wednesday, 12'th May 2021
-- First Patient to Be Enrolled this Week in Phase 3 Clinical Trial of Sabizabulin (VERU-111) in High Risk Hospitalized COVID-19 Patients-- --New Drug Application Accepted for Review by FDA for Propri
VERU Stock: From $8.70 To $10.43 (19.89% Increase) Pre-Market Explanation
08:56am, Wednesday, 05'th May 2021
The stock price of Veru Inc (NASDAQ: VERU) increased from $8.70 to $10.43 pre-market. This is why it happened.
MIAMI, May 05, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, tod
MIAMI, April 21, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, t
Are Options Traders Betting on a Big Move in Veru (VERU) Stock?
09:05am, Monday, 05'th Apr 2021
Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately.
Veru to Present at the Oppenheimer 31st Annual Healthcare Conference
08:30am, Tuesday, 09'th Mar 2021
MIAMI, March 09, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, t
Veru mulls selling female health business
09:59am, Monday, 08'th Mar 2021
Shares of Veru Inc. gained 6.5% in trading on Monday after the company said it is considering selling its female condom product. Veru hired Morgan Stanley & Co. as its financial advisor, saying the fe
Veru to Participate in Fireside Chat at the H.C. Wainwright Global Life Sciences Conference
08:30am, Tuesday, 02'nd Mar 2021
MIAMI, March 02, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, t
Veru (VERU) Reports Q1 Loss, Tops Revenue Estimates (Revised)
01:39pm, Monday, 01'st Mar 2021
Veru (VERU) delivered earnings and revenue surprises of 50.00% and 37.56%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Veru's VERU-111 Moves Into Pivotal COVID-19 Study
12:05pm, Monday, 01'st Mar 2021
Veru Inc (NASDAQ: VERU) will start testing VERU-111 in the registrational Phase 3 study in hospitalized patients who have COVID-19 virus infection and are at high risk for Acute Respiratory Distre
Veru Submits New Drug Application for Proprietary TADFIN for BPH
08:30am, Tuesday, 23'rd Feb 2021
--TADFIN™, Tadalafil 5mg and Finasteride 5mg formulated capsule, for daily oral dosing to improve compliance-- --Administration of Tadalafil and Finasteride is more effective than Finasteride alone
Why Veru, Invitae And More Are Moving Today
11:52am, Thursday, 18'th Feb 2021
Community Health Systems (NYSE: CYH) shares are trading higher after the company reported better-than-expected fourth-quarter sales results. Community Health Systems is the largest publicly owned hosp
